Skip to content

Clinical trials

Triple Negative Breast Neoplasms trials in the United States with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Triple Negative Breast Neoplasms Status: Unknown status Country / region: United States Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20112
20152
20161
20174
20183
20194
20202
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status19

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Infinity Pharmaceuticals, Inc.2
Northwestern University2
Adlai Nortye Biopharma Co., Ltd.1
Animated Dynamics, Inc.1
Cynvenio Biosystems1
Eileen Connolly1
Merrimack Pharmaceuticals1
MultiVir, Inc.1
NuGenerex Immuno-Oncology1
OncXerna Theraputics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Triple Negative Breast Neoplasms19
Breast Neoplasms11
Carcinoma, Non-Small-Cell Lung5
Stomach Neoplasms4
Colorectal Neoplasms3
Ovarian Neoplasms3
Carcinoma, Renal Cell2
Carcinoma, Transitional Cell2
Endometrial Neoplasms2
Melanoma2

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.